The lack of high-quality, up-to-date clinical guidance on monkeypox is hindering effective and safe treatment of the infection worldwide, according to a review led by an international team of researchers.
Researchers from Britain’s Oxford, Australia’s University of Bristol and the Liverpool School of Tropical Medicine said current guidance lacks sufficient detail, fails to include different groups and is contradictory.
He said that due to the lack of clear guidelines, there is uncertainty among physicians treating patients with monkeypox, which could affect patient care.
“This research highlights the need for a rigorous framework for building guidelines before a pandemic and a recognized platform to rapidly review and update guidance during outbreaks as new evidence emerges,” the researchers said.
“Human (moneypox) poses a challenge even in high-resource settings with well-resourced health care systems,” the researchers wrote in a paper published in the open access journal ‘BMJ Global Health.’ may affect clinics with limited previous experience in managing patients with PTSD.”
The team searched six major research databases for relevant material published in multiple languages between mid-October 2021 and May 2022. These databases are ‘grey literature’ – policy documents, newspapers and reports.
The researchers found 14 relevant guidelines. According to the Guidelines for Evaluation for Research and Evaluation 2 (AGREE) system, most were of low quality, scoring an average of two out of a possible seven and most lacked details and covered only a narrow range of subjects. has gone.
